HackerFeeds
All ransomware incidents
P

Ransomware group N0n hits Pharvaris N.V.

MEDIUM
·Healthcare·NL·2026-11-09

Pharvaris N.V. — a healthcare target operating in NL has been listed by the N0n ransomware group on 2026-11-09. The information below reflects what the threat actor has publicly claimed on their leak site; the details have not been independently verified.

Incident Report

Target OrganizationPharvaris N.V.
Threat Group
N0n
SummaryPharvaris N.V., a healthcare organization in the Netherlands, was listed by the N0n ransomware group on its leak site on 2026-11-16.
Date of Breach2026-11-09
Discovery Date2026-11-16
RegionNL
Target Domain—
Business SectorHealthcare
Severity
MEDIUM

Claim by N0n

biopharmaceutical (hereditary angioedema) · Netherlands | Your hereditary angioedema market corpus: patient dimensions covering 1,916,257 and 1,549,358 distinct patients with birth years and genders, 40,751,823 patient activity rows, and 851,235 filtered prescription claim rows with diagnosis level claim counts for the angioedema population; Prescriber and provider dimensions of 3,178,279 and 2,984,097 rows with names, addresses, phone numbers, DEA numbers and NPIs; An identified patient output of 11,282 rows from your line of therapy analysis, and the patient identification logic behind it | [NOT PAID — EXPOSED] Initially listed anonymously by N0n as "Company #207" on 2026-11-09.

Posted by the N0n threat actor on its public leak site. This is the group's own statement and has not been independently verified by HackerFeeds.

Sources

Leak post (onion / Tor)

tor

http://nongzecboljwv3yfndkggsybsglfrkffw7bvk2zemuteoxe6etpusnad.onion#v-pharvaris

Open this URL in Tor Browser. Browsing leak sites carries real risk — view passively, never click further.

Disclaimer

HackerFeeds does not engage in the exfiltration, downloading, taking, hosting, viewing, reposting, or disclosure of any stolen information. All breach data reported here is sourced from publicly available threat intelligence feeds for awareness purposes only.